36
In band
Moving averages
SMA 200$6.27-31.10%
Company profile
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of new clean-surface nanotechnology (CSN) therapies. The company is headquartered in Salt Lake City, Utah.
SectorConsumer Defensive
IndustryPackaged Foods
Market cap$55.84M
P/E ratioNone
EPS$-3.25
Beta0.971
Dividend yield0.00%
52-week high$13.50
52-week low$3.50
Similar stocks in Packaged Foods
RSI alerts for CLNN
Get an email the moment Clene Inc. crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 12 August 2026 at 8:27 PM EDT